# I.V Papavrine for Labor Induction in Term PROM

> **NCT07517796** · PHASE4 · RECRUITING · sponsor: **Western Galilee Hospital-Nahariya** · enrollment: 110 (estimated)

## Conditions studied

- Premature Rupture of Membranes

## Interventions

- **DRUG:** Papaverine arm
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07517796
- **Lead sponsor:** Western Galilee Hospital-Nahariya
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-22
- **Primary completion:** 2027-10-22
- **Final completion:** 2027-10-22
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07517796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07517796, "I.V Papavrine for Labor Induction in Term PROM". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07517796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*